2025-05-29 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the provided data, formatted as requested.

## Natera Inc. (NTRA) Stock Analysis

### 1. Performance vs. S&P 500 (VOO)

*   **Ticker:** NTRA
*   **Company Overview:** Natera Inc. is a diagnostics company specializing in genetic testing for reproductive health, oncology, and organ health.

**Cumulative Returns:**

*   NTRA: 129.67%
*   VOO (S&P 500): 82.45%

**Relative Performance (Spread):**

*   Current: 47.2%
*   Range: Max 626.1%, Min -43.4%
*   Relative Spread: 13.5%

**Analysis:** NTRA has significantly outperformed the S&P 500 in cumulative return. The spread of 47.2% indicates notable outperformance. However, a relative spread of 13.5% suggests that the current outperformance is closer to the lower end of its historical range, meaning it has performed much better than the S&P500 at times in the past.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2015-2017  | -6.0%  | 62.4% | -31.0%  | -0.0   | 1.2    |
| 2016-2018  | 29.0%  | 80.1% | 11.0%   | 0.1    | 1.9    |
| 2017-2019  | 159.0% | 80.1% | 130.0%  | 1.2    | 4.6    |
| 2018-2020  | 530.0% | 80.1% | 505.0%  | 0.6    | 13.6   |
| 2019-2021  | 356.0% | 62.9% | 301.0%  | 0.2    | 12.8   |
| 2020-2022  | -119.0% | 62.9% | -125.0% | 0.3    | 5.5    |
| 2021-2023  | -482.0% | 69.9% | -499.0% | 1.2    | 8.6    |
| 2022-2024  | -75.0%  | 70.5% | -92.0%  | 1.3    | 21.6   |
| 2023-2025  | 78.0%  | 72.8% | 49.0%   | 0.9    | 22.0   |

*   **CAGR (Compound Annual Growth Rate):** NTRA's CAGR has varied significantly over different periods, ranging from negative values to very high growth rates.
*   **MDD (Maximum Drawdown):** MDD is consistently high, indicating significant volatility and risk.
*   **Alpha:** Alpha is generally high (both positive and negative), indicating periods of significant outperformance and underperformance compared to the benchmark (S&P 500).
*   **Beta:** Beta values are generally low, suggesting that NTRA's price movements are not strongly correlated with the overall market. In some periods, the negative Beta values may indicate an inverse relationship.
*   **Cap(B):** The company's market capitalization has varied from $1.2B to $22.0B, reflecting changes in investor sentiment and company performance.

### 2. Recent Price Action

*   **Current Price:** $161.21
*   **Previous Close:** $157.16
*   **Change:** 2.58%
*   **5-day Moving Average:** $155.05
*   **20-day Moving Average:** $154.62
*   **60-day Moving Average:** $148.87

**Analysis:** NTRA's price is above its 5, 20, and 60-day moving averages, indicating an upward trend. The 2.58% increase from the previous close suggests positive momentum.

### 3. Market Risk Indicators and Expected Return

*   **MRI (Market Risk Indicator):** 0.366 (Low Risk)
*   **RSI (Relative Strength Index):** 51.23
*   **PPO (Percentage Price Oscillator):** 0.2
*   **Hybrid Signal:** Cash_14%_Buy 80% of cash (935 shares - Caution - MRI:0.37)
*   **Recent Relative Divergence Change (20-day):** 0.6 (+) (Short-term increase)
*   **Expected Return (%):** 123.6%

**Analysis:**

*   The MRI indicates a "Low Risk" environment.
*   The RSI of 51.23 suggests a neutral condition, neither overbought nor oversold.
*   PPO is at 0.2, implying that the short-term moving average is slightly above the long-term moving average, signaling a weak upward trend.
*   The "Hybrid Signal" suggests a cautious approach, recommending buying 80% of available cash while maintaining a 14% cash reserve.
*   The recent increase in relative divergence signals short-term positive momentum.
*   The significantly high expected return of 123.6% suggests optimism about NTRA's long-term growth potential compared to the S&P 500.
*   The price jump relative to the previous close suggests some recent positive news or event affecting the stock.

### 4. Recent News & Significant Events

*   **2025-05-25:** Major business developments, regulatory changes, or market events.
*   **2025-05-26:** Analyst discussions on performance and outlook in the context of industry trends and global economic factors.
*   **2025-05-27:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-05-28:** Experts highlight risks and opportunities, advising monitoring of news and company announcements.

**Analysis:** The recent news suggests heightened activity and volatility around NTRA, driven by business developments, analyst discussions, and potential earnings/executive actions.

### 5. Recent Earnings Analysis

| 날짜         | EPS    | 매출        |
|--------------|--------|-------------|
| 2025-05-09   | -0.5   | 0.50 B$    |
| 2024-11-12   | -0.26  | 0.44 B$    |
| 2024-08-09   | -0.3   | 0.41 B$    |
| 2024-05-10   | -0.56  | 0.37 B$    |
| 2025-05-09   | -0.56  | 0.37 B$    |

**Analysis:** NTRA has consistently reported negative EPS, indicating ongoing losses. However, revenue has generally been increasing over the last few quarters, which is a positive sign. The EPS of -0.5 and -0.56 for May 9th suggests a significant lack of earnings relative to revenue.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $0.50B    | 63.12%        |
| 2024-12-31   | $0.48B    | 62.94%        |
| 2024-09-30   | $0.44B    | 61.79%        |
| 2024-06-30   | $0.41B    | 58.83%        |
| 2024-03-31   | $0.37B    | 56.72%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-03-31   | $1.24B    | -5.40% |
| 2024-12-31   | $1.20B    | -4.50% |
| 2024-09-30   | $0.88B    | -3.60% |
| 2024-06-30   | $0.84B    | -4.48% |
| 2024-03-31   | $0.79B    | -8.51% |

**Analysis:**

*   **Revenue and Profitability:** Revenue is steadily increasing, and profit margins are high and improving, which is a positive trend.
*   **Capital and Profitability:** Equity is increasing, indicating a strengthening balance sheet. However, the negative ROE (Return on Equity) reflects the company's ongoing unprofitability.

### 7. Overall Summary

Natera Inc. (NTRA) shows a mixed picture.

**Positives:**

*   Significant outperformance compared to the S&P 500 in cumulative returns.
*   Recent positive price momentum.
*   "Low Risk" market environment according to the MRI.
*   Increasing revenue and improving profit margins.
*   High expected return, suggesting significant long-term growth potential.
*   Increasing equity, indicating a strengthening balance sheet.

**Negatives:**

*   High historical volatility (MDD).
*   Consistently negative EPS, indicating a lack of current profitability.
*   Negative ROE, reflecting ongoing unprofitability.
*   Recent volatility and activity suggest potential uncertainty due to business developments, regulatory changes, and analyst discussions.

**Conclusion:**

NTRA is a high-growth, high-risk stock. It has demonstrated the ability to significantly outperform the market but also experiences significant volatility. The company is not currently profitable, but revenue is growing, and profit margins are improving. The recent news and analyst discussions suggest potential catalysts for future price movements.

**Recommendation:**

The hybrid signal of "Cash_14%_Buy 80% of cash (935 shares - Caution)" seems appropriate. Given the potential for high returns and the inherent risks, a balanced approach is warranted. Investors should closely monitor company news, earnings reports, and analyst commentary to stay informed about developments that could impact the stock's future performance.
